These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31144016)

  • 21. Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
    Yang GL; Guo J; Pudasaini B; Yuan P; Gong SG; Wang L; Zhao QH; Yang WL; Jiang R; Zhou C; Liu JM
    Clin Respir J; 2019 Sep; 13(9):545-554. PubMed ID: 31295761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
    Lewis RA; Durrington C; Condliffe R; Kiely DG
    Eur Respir Rev; 2020 Jun; 29(156):. PubMed ID: 32414745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An easy method for monitoring patients with pulmonary Hypertension: P-wave dispersion.
    Cimen AO; Emet S
    Cardiovasc J Afr; 2020; 31(4):75-80. PubMed ID: 31544202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
    Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six-minute walk test closely correlates to "real-life" outdoor walking capacity and quality of life in patients with intermittent claudication.
    Nordanstig J; Broeren M; Hensäter M; Perlander A; Osterberg K; Jivegård L
    J Vasc Surg; 2014 Aug; 60(2):404-9. PubMed ID: 24690492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation Between Right Ventricular Echocardiography Measurements and Functional Capacity in Patients With Pulmonary Arterial Hypertension.
    Woo JL; DiLorenzo MP; Rosenzweig E; Pasumarti N; Villeda GV; Berman-Rosenzweig E; Krishnan U
    Tex Heart Inst J; 2022 Nov; 49(6):. PubMed ID: 36350291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
    J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of clinical and physiological relations of daily physical activity in precapillary pulmonary hypertension.
    Panagiotou M; Johnson MK; Louvaris Z; Baker JS; Church AC; Peacock AJ; Vogiatzis I
    J Appl Physiol (1985); 2017 Oct; 123(4):851-859. PubMed ID: 28663381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension.
    Arvanitaki A; Mouratoglou SA; Evangeliou A; Grosomanidis V; Hadjimiltiades S; Skoura L; Feloukidis C; Farmakis D; Karvounis H; Giannakoulas G
    Heart Lung Circ; 2020 Jan; 29(1):142-148. PubMed ID: 30686644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical Activity and Its Association with Traditional Outcome Measures in Pulmonary Arterial Hypertension.
    Minhas J; Shou H; Hershman S; Zamanian R; Ventetuolo CE; Bull TM; Hemnes A; Chakinala MM; Mathai S; Al-Naamani N; Ellenberg S; Matura LA; Kawut SM; Shcherbina A
    Ann Am Thorac Soc; 2022 Apr; 19(4):572-582. PubMed ID: 34473938
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of 6-min Walk Test on pro-BNP Levels in Patients with Pulmonary Arterial Hypertension.
    Pathak V; Aris R; Jensen BC; Huang W; Ford HJ
    Lung; 2018 Jun; 196(3):315-319. PubMed ID: 29564533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study.
    Rosenzweig E; Villeda GAV; Crook S; Koli F; Rosenzweig EB; Krishnan US
    Tex Heart Inst J; 2023 Oct; 50(5):. PubMed ID: 37853911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients.
    Romaniello A; Rubattu S; Gigante A; Simonelli F; Grimaldi MC; D'Angelo A; Alunni D; Sada L; Gasperini ML; Marchitti S; Volpe M; Rosato E
    J Cardiovasc Med (Hagerstown); 2019 Nov; 20(11):771-779. PubMed ID: 31397686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.
    Al-Naamani N; Palevsky HI; Lederer DJ; Horn EM; Mathai SC; Roberts KE; Tracy RP; Hassoun PM; Girgis RE; Shimbo D; Post WS; Kawut SM;
    Ann Am Thorac Soc; 2016 Jan; 13(1):25-30. PubMed ID: 26501464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat stress is associated with reduced health status in pulmonary arterial hypertension: a prospective study cohort.
    Jehn M; Gebhardt A; Liebers U; Kiran B; Scherer D; Endlicher W; Witt C
    Lung; 2014 Aug; 192(4):619-24. PubMed ID: 24816966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of brain natriuretic peptide in long-term follow-up of pulmonary arterial hypertension.
    Leuchte HH; Holzapfel M; Baumgartner RA; Neurohr C; Vogeser M; Behr J
    Chest; 2005 Oct; 128(4):2368-74. PubMed ID: 16236896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
    Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Karvounis H; Sfetsios T; Koliakos G; Parcharidis G; Settas L
    Int J Cardiol; 2007 Sep; 121(1):135-7. PubMed ID: 17088004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.